Fresenius | FRE - Cash And Equivalent

Fresenius reported EUR2.75B in Cash and Equivalent for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cash And Equivalent Change
Akzo Nobel AKZA:NA EUR 1.45B 104M
Alcon AG ALC:SW USD 980M 197M
AstraZeneca AZN:LN USD 6.17B 1.71B
BASF BAS:GR EUR 2.52B 667M
Bayer BAYN:GR EUR 5.17B 810M
Davita Healthcare Partners DVA:US USD 244.09M 123.42M
E.ON EOAN:GR EUR 7.32B 232M
Essilor EI:FP EUR 1.96B 250M
Fresenius FRE:GR EUR 2.75B 621M
Getinge GETIB:SS SEK 5.68B 837M
Givaudan GIVN:VX CHF 475M 165M
GlaxoSmithKline GSK:LN GBP 3.72B 117M
GN Store Nord GN:DC DKK 990M 120M
Hikma Pharmaceutical HIK:LN USD 270M 247M
Lonza Group LONN:SW CHF 1.34B 187M
Merck MRK:GR EUR 1.85B 250M
Novartis NOVN:VX USD 7.52B 1.21B
Roche Holding ROG:VX 4.99B 676M
RWE RWE:GR EUR 3.31B 1.31B